G24.0

Clinical Causes: Use of antipsychotic medications (e.g., haloperidol, chlorpromazine) Dopaminergic agents used in Parkinson's disease treatment Metoclopramide, a drug used for nausea and gastrointestinal issues Certain antidepressants and antiemetics Rapid dose escalation or high doses of the causative drugs Genetic predisposition affecting drug response History of previous movement disorders

Key Symptoms: Involuntary muscle contractions, especially in the face, neck, and tongue Arched back or abnormal postures Facial grimacing Stiff neck and shoulder muscles Difficulty speaking or swallowing Eye movement abnormalities Pain or discomfort due to muscle contractions Sudden or gradual onset of symptoms after starting or increasing medication dose

Diagnosis Path: Diagnosis is primarily clinical, based on patient history and symptom presentation. Medical providers will review recent medication use, especially neuroleptic or dopamine-affecting drugs. Physical examinations focus on identifying characteristic involuntary movements and postures. Imaging or laboratory tests are generally not necessary but may be used to rule out other neurological conditions. The timing of symptom onset following drug administration is a key factor in diagnosis.

Treatment Protocols: Management involves discontinuing or adjusting the offending medication, under medical supervision. Symptomatic treatments may include administering anticholinergic medications, such as benztropine or diphenhydramine, to reduce muscle contractions. In some cases, additional therapies, like benzodiazepines, may be prescribed for muscle relaxation. Prompt treatment can lead to symptom resolution, especially if caught early. Ongoing monitoring and medication adjustments are crucial to prevent recurrence.